BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30006677)

  • 1. Myxoid glioneuronal tumor of the septum pellucidum and lateral ventricle is defined by a recurrent PDGFRA p.K385 mutation and DNT-like methylation profile.
    Solomon DA; Korshunov A; Sill M; Jones DTW; Kool M; Pfister SM; Fan X; Bannykh S; Hu J; Danielpour M; Li R; Johnston J; Cham E; Cooney T; Sun PP; Oberheim Bush NA; McDermott M; Van Ziffle J; Onodera C; Grenert JP; Bastian BC; Villanueva-Meyer JE; Pekmezci M; Bollen AW; Perry A
    Acta Neuropathol; 2018 Aug; 136(2):339-343. PubMed ID: 30006677
    [No Abstract]   [Full Text] [Related]  

  • 2. Myxoid glioneuronal tumor, PDGFRA p.K385-mutant: clinical, radiologic, and histopathologic features.
    Lucas CG; Villanueva-Meyer JE; Whipple N; Oberheim Bush NA; Cooney T; Chang S; McDermott M; Berger M; Cham E; Sun PP; Putnam A; Zhou H; Bollo R; Cheshier S; Poppe MM; Fung KM; Sung S; Glenn C; Fan X; Bannykh S; Hu J; Danielpour M; Li R; Alva E; Johnston J; Van Ziffle J; Onodera C; Devine P; Grenert JP; Lee JC; Pekmezci M; Tihan T; Bollen AW; Perry A; Solomon DA
    Brain Pathol; 2020 May; 30(3):479-494. PubMed ID: 31609499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myxoid glioneuronal tumor: Histopathologic, neuroradiologic, and molecular features in a single center series.
    Caporalini C; Scagnet M; Giunti L; Cetica V; Mei D; Conti V; Moscardi S; Macconi L; Giordano F; D'Incerti L; Genitori L; Guerrini R; Buccoliero AM
    Neoplasia; 2023 Mar; 37():100885. PubMed ID: 36764090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Septal dysembryoplastic neuroepithelial tumor: a comprehensive clinical, imaging, histopathologic, and molecular analysis.
    Chiang JCH; Harreld JH; Tanaka R; Li X; Wen J; Zhang C; Boué DR; Rauch TM; Boyd JT; Chen J; Corbo JC; Bouldin TW; Elton SW; Liu LL; Schofield D; Lee SC; Bouffard JP; Georgescu MM; Dossani RH; Aguiar MA; Sances RA; Saad AG; Boop FA; Qaddoumi I; Ellison DW
    Neuro Oncol; 2019 Jun; 21(6):800-808. PubMed ID: 30726976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myxoid glioneuronal tumor, PDGFRA p.K385L-mutant, arising in midbrain tectum with multifocal CSF dissemination.
    Kleinschmidt-DeMasters BK; Chiang J; Donson AM; Borges T; Gilani A
    Brain Pathol; 2022 Jan; 32(1):e13008. PubMed ID: 34297434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gliomatosis cerebri: no evidence for a separate brain tumor entity.
    Herrlinger U; Jones DTW; Glas M; Hattingen E; Gramatzki D; Stuplich M; Felsberg J; Bähr O; Gielen GH; Simon M; Wiewrodt D; Schabet M; Hovestadt V; Capper D; Steinbach JP; von Deimling A; Lichter P; Pfister SM; Weller M; Reifenberger G
    Acta Neuropathol; 2016 Feb; 131(2):309-319. PubMed ID: 26493382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosette-forming glioneuronal tumor of the septum pellucidum with extension to the supratentorial ventricles: rare case with genetic analysis.
    Xiong J; Liu Y; Chu SG; Chen H; Chen HX; Mao Y; Wang Y
    Neuropathology; 2012 Jun; 32(3):301-5. PubMed ID: 22017246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysembryoplastic Neuroepithelial Tumor of the Septum Pellucidum and the Supratentorial Midline: Histopathologic, Neuroradiologic, and Molecular Features of 7 Cases.
    Gessi M; Hattingen E; Dörner E; Goschzik T; Dreschmann V; Waha A; Pietsch T
    Am J Surg Pathol; 2016 Jun; 40(6):806-11. PubMed ID: 26796505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents.
    Ricci R; Martini M; Ravegnini G; Cenci T; Milione M; Lanza P; Pierconti F; Santini D; Angelini S; Biondi A; Rosa F; Alfieri S; Clemente G; Persiani R; Cassano A; Pantaleo MA; Larocca LM
    Clin Epigenetics; 2019 Jan; 11(1):2. PubMed ID: 30616628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysembryoplastic neuroepithelial tumor-like neoplasm of the septum pellucidum: review of 2 cases with chromosome 1p/19q and IDH1 analysis.
    Xiong J; Liu Y; Chu SG; Chen H; Chen HX; Mao Y; Wang Y
    Clin Neuropathol; 2012; 31(1):31-8. PubMed ID: 22192702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Multifocal Glioneuronal Tumor with RGNT-Like Morphology Occupying the Supratentorial Ventricular System and Infiltrating the Brain Parenchyma.
    Morassi M; Vivaldi O; Cobelli M; Liserre B; Zorzi F; Bnà C
    World Neurosurg; 2020 Jan; 133():196-200. PubMed ID: 31606508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of MGMT promoter methylation sites correlating with gene expression and IDH1 mutation in gliomas.
    Zhang J; Yang JH; Quan J; Kang X; Wang HJ; Dai PG
    Tumour Biol; 2016 Oct; 37(10):13571-13579. PubMed ID: 27468718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of TERT promoter mutation on IDH mutation and MGMT promoter methylation in diffuse gliomas.
    Kim HS; Kwon MJ; Song JH; Kim ES; Kim HY; Min KW
    Pathol Res Pract; 2018 Jun; 214(6):881-888. PubMed ID: 29650441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polar spongioblastoma: A high-grade glioma that does not contain the IDH1 mutation or 1p/19q LOH.
    Nagaishi M; Tanaka Y; Iwatate K; Yokoo H; Ueki K; Hyodo A; Nakazato Y
    Neuropathology; 2010 Oct; 30(5):547-52. PubMed ID: 20102524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case of primary diffuse leptomeningeal gliomatosis.
    Yamasaki K; Yokogami K; Ohta H; Yamashita S; Uehara H; Sato Y; Takeshima H
    Brain Tumor Pathol; 2014 Jul; 31(3):177-81. PubMed ID: 24473978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of temozolomide is correlated with 1p loss and methylation of the deoxyribonucleic acid repair gene MGMT in malignant gliomas.
    Ishii D; Natsume A; Wakabayashi T; Hatano H; Asano Y; Takeuchi H; Shimato S; Ito M; Fujii M; Yoshida J
    Neurol Med Chir (Tokyo); 2007 Aug; 47(8):341-9; discussion 350. PubMed ID: 17721049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation.
    Brito C; Azevedo A; Esteves S; Marques AR; Martins C; Costa I; Mafra M; Bravo Marques JM; Roque L; Pojo M
    BMC Cancer; 2019 Oct; 19(1):968. PubMed ID: 31623593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysembryoplastic neuroepithelial tumor in the left lateral ventricle.
    Ongürü O; Deveci S; Sirin S; Timurkaynak E; Günhan O
    Minim Invasive Neurosurg; 2003 Oct; 46(5):306-9. PubMed ID: 14628248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact on prognosis of the regional distribution of MGMT methylation with respect to the CpG island methylator phenotype and age in glioma patients.
    Mur P; Rodríguez de Lope Á; Díaz-Crespo FJ; Hernández-Iglesias T; Ribalta T; Fiaño C; García JF; Rey JA; Mollejo M; Meléndez B
    J Neurooncol; 2015 May; 122(3):441-50. PubMed ID: 25682093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysembryoplastic neuroepithelial tumor-like neoplasm of the septum pellucidum: a lesion often misdiagnosed as glioma: report of 10 cases.
    Baisden BL; Brat DJ; Melhem ER; Rosenblum MK; King AP; Burger PC
    Am J Surg Pathol; 2001 Apr; 25(4):494-9. PubMed ID: 11257624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.